Dean McGee Eye Institute

Dean McGee Eye Institute

Hospitals and Health Care

Oklahoma City, Oklahoma 1,136 followers

The Premier Eye Center in Oklahoma

About us

The Dean McGee Eye Institute is dedicated to serving all Oklahomans and the global community through excellence and leadership in patient care, education, and vision research. No other group of eye care providers in the state of Oklahoma or surrounding region can match the breadth and depth of specialty eye care available at the Dean McGee Eye Institute (DMEI). We have the physicians and surgeons to care for you regardless of your eye care needs and offer care in all the major subspecialties of ophthalmology: Comprehensive Ophthalmology Cornea & External Disease Glaucoma Low Vision Rehabilitation Neuro-Ophthalmology Ocular Oncology (Eye Cancer) Ophthalmic Plastic and Reconstructive Surgery Pediatric Ophthalmology and Strabismus Retina and Vitreous Uveitis

Website
http://www.dmei.org
Industry
Hospitals and Health Care
Company size
201-500 employees
Headquarters
Oklahoma City, Oklahoma
Type
Nonprofit
Founded
1975
Specialties
Ophthalmology, Corneal and External Diseases, Glaucoma, Refractive Surgery, Neuro-Ophthalmology, Contact Lenses, Ophthalmic Pathology and Oncology, Comprehensive Ophthalmology, Low Vision Rehabilitation, Neuro-Ophthalmology, Ocular Oncology (Eye Cancer), Ophthalmic Plastic and Reconstructive Surgery, Pediatric Ophthalmology and Strabismus, Retina and Vitreous, Uveitis, Vision Research, and OU Department of Ophthalmology

Locations

Employees at Dean McGee Eye Institute

Updates

  • Dean McGee Eye Institute reposted this

    View profile for Mahmoud A. Khaimi, MD, graphic

    Clin Prof & James P. Luton, MD Endowed Chair in Ophthal, Dir of Glauc Fellowship, Surgical Innovator, Team Lead Ophthal OKC THUNDER NBA, Chief Medical Consultant - Nova Eye Medical

    ASCRS 2024 is on the horizon, and our DMEI team is gearing up for some well-deserved time in the spotlight to share our advancements and findings in canaloplasty. I must take a moment to express how proud I am of our fellows and residents. This year, we're thrilled to bring the groundbreaking #iTrack #canaloplasty technology into focus with an array of presentations: 6 podium presentations, 1 presented poster and 2 e-Posters. Each session will offer nuanced insights into the clinical outcomes and the versatile applications of canaloplasty in managing #glaucoma. Below is a summary of our group representatives’ presentations scheduled in the ASCRS's official scientific program – be sure not to miss them! PODIUM PRESENTATIONS Saturday, April 6, 2024 @ BCEC - Meeting Level 2, Room 259A   Ahmad Abdel-Aty, MD Ab-Interno Canaloplasty in Primary Angle-Closure Spectrum+ Time: 10:10 AM   Raman Michael, MD Investigating the Consistency in Outcomes of Ab-Interno Canaloplasty as a Standalone Procedure Time: 10:15 AM Neal Rangu, BA; Mohsain Gill, MD; Kamran Riaz, MD; Mahmoud A. Khaimi, MD Performing Ab-Interno Canaloplasty Post Keratoplasty in Steroid-Induced Glaucoma Eyes – 3 Years Outcomes Time: 10:20 AM     Sunday, April 7, 2024 @ BCEC - Meeting Level 2, Room 259A   Umar D. Sandhu, BA; Kamran M. Riaz, MD; Mahmoud A. Khaimi, MD Performing Ab-Interno Canaloplasty Post Keratoplasty – 2 Year Outcomes Time: 08:40 AM   Juliana Bryant, MD Ab-Interno Canaloplasty Standalone Versus Combined with Cataract Surgery – 36-Month Outcomes in +1000 Eyes Time: 4:39 PM   Manish Harrigill, MD Performing Ab-Interno Canaloplasty in PACG Eyes Across Different Stages of Glaucoma Severity Time: 4:54 PM     PRESENTED POSTER   Saturday, April 6, 2024 @ BCEC - Poster Presentation Area   Juliana Bryant, MD Canaloplasty MIGS Characteristics: Correlation between Pressurized OVD Volume and Effectiveness on IOP and Medications in PACG Eyes Time: 2:15 PM           e-POSTERS   Raman A. Michael, MD Canaloplasty Performed with an Ab-Interno Technique for Pseudoexfoliative or Pigmentary Glaucoma Eyes – 12 Months Results   Raman A. Michael, MD Effectiveness and Safety Profile of Standalone Ab-Interno Canaloplasty Using the iTrack in Uncontrolled (>18mmHg) Glaucoma Eyes      #ASCRS2024 #iTrack #MIGS #Ophthalmology #GlaucomaTreatment    #ASCRS2024 #iTrack #MIGS #Ophthalmology #GlaucomaTreatment American Society of Cataract and Refractive Surgery (ASCRS) Dean McGee Eye Institute

    • No alternative text description for this image
  • View organization page for Dean McGee Eye Institute, graphic

    1,136 followers

    👀

    View profile for Mahmoud A. Khaimi, MD, graphic

    Clin Prof & James P. Luton, MD Endowed Chair in Ophthal, Dir of Glauc Fellowship, Surgical Innovator, Team Lead Ophthal OKC THUNDER NBA, Chief Medical Consultant - Nova Eye Medical

    When it comes to treating our glaucoma patients, consistent, predictable outcomes are important. Our paper recently published in Clinical Ophthalmology highlights that canaloplasty achieves consistent eye-by-eye results, achieving a near universal IOP reduction in patients and reducing both IOP and medications in almost all patients. Norbert Koerber; Mark Gallardo; Simon Ondrejka https://buff.ly/3w4jY5m #consistency #canaloplasty #iTrack #glaucoma #predictable #repeatable #reliable #consistent

Similar pages

Browse jobs